CLINICAL_TRIALS
trial_result
· 2022-01-19
Clinical Trial Update: Study of SkQ1 as Treatment for Dry-eye Syndrome [Phase 3]
Summary
Phase 3 trial of SkQ1 for dry eye syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mitotech, SA | Conditions: Dry Eye Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2022-01-19